Mega Genomics Ltd. has announced a delay in the publication of its 2025 interim financial results, originally due by August 31, 2025. The company, along with its subsidiaries, is also facing continued suspension of trading on the Hong Kong Stock Exchange, effective since April 1, 2025. This delay is linked to pending matters from previous announcements, including the 2024 annual results and report. Shareholders and investors are advised to exercise caution.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mega Genomics Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.